[144] Phreesia, Inc. SEC Filing

Rhea-AI Filing Summary

Phreesia, Inc. insider filing notifies a proposed sale of 6,328 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $147,343.68, and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 upon restricted stock vesting as compensation. The filer also reported three sales during the past three months totaling 103,164 shares for gross proceeds of $3,210,162.74 (sales on 07/17/2025, 08/27/2025 and 08/28/2025). The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Acquisition disclosed: The 6,328 shares were acquired through restricted stock vesting as compensation, a standard and transparent compensation mechanism
• Full disclosure of prior sales: The filer reported three prior sales totaling 103,164 shares and gross proceeds of $3,210,162.74, providing transparency on recent insider transactions

Negative

• Insider selling activity: Significant prior disposals including a single sale of 92,247 shares on 08/27/2025 for approximately $2.95M, which may be viewed negatively by some market participants
• Concentration of recent sales: Large aggregated sales in the past three months could raise questions about insider liquidity needs or portfolio rebalancing

Insights

Securities Analyst

TL;DR: Insider proposes a small sale following recent large dispositions; acquisition was via compensation vesting.

The filing shows a proposed disposal of 6,328 shares valued at about $147k, acquired through restricted stock vesting on 09/11/2025. Recent past sales total 103,164 shares for roughly $3.21M, indicating meaningful insider liquidity in the prior quarter. For investors, the activity is factual disclosure of trading; it does not on its face reveal nonpublic adverse information and is consistent with compensation realization and subsequent sales.

Corporate Governance Expert

TL;DR: Form 144 documents compliant disclosure of insider sales and vested compensation; no governance red flags presented.

The filer declares the shares were received via restricted stock vesting and that the sale will be executed through a broker on the NYSE. The statement affirms no undisclosed material adverse information. Multiple recent sales are disclosed, which is important for transparency about insider liquidity and potential dilution, but the filing contains no allegations or governance issues beyond routine insider selling.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6328	147343.68	59914473	09/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Restricted Stock Vesting	Issuer			6328	09/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Chaim Indig 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	3171	85254.87
Chaim Indig 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/27/2025	92247	2953431.29
Chaim Indig 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/28/2025	7746	251476.58

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Phreesia (PHR) Form 144 filed on this notice disclose?

The filing discloses a proposed sale of 6,328 common shares on 09/16/2025 via Fidelity with an aggregate market value of $147,343.68, acquired on 09/11/2025 through restricted stock vesting.

How many shares did the insider sell in the past three months for Phreesia (PHR)?

The filer sold a total of 103,164 shares in three transactions on 07/17/2025, 08/27/2025, and 08/28/2025 for combined gross proceeds of $3,210,162.74.

Were the shares being sold acquired as compensation or purchased?

The 6,328 shares proposed for sale were acquired on 09/11/2025 by restricted stock vesting and paid as compensation.

Through which broker will the proposed sale be executed?

The proposed sale is to be executed through Fidelity Brokerage Services LLC and is expected to occur on the NYSE.

Does the filer assert possession of undisclosed material information?

By signing the notice, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.